Thu.Aug 15, 2024

article thumbnail

BioAktive Reveals Pore-reducing, Skin-smoothing Effects of Lactomaizol Postbiotic

MedEsthetics

Previously described for sebum regulation and gentle cleansing, Lactomaizol has now been shown in vivo to shrink pores and smooth skin.

Pores 78
article thumbnail

Hair-Raising Challenges

Dermatology Times

Zoe Draelos, MD, presents vignettes based on common hair problems that patients face, with possible dermatologic solutions.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

NextGen Actives Launches Buzzy Apinol360 Propolis-derived Retinol Alternative

MedEsthetics

Described as an antioxidant and antimicrobial "powerhouse," the product has been clinically proven at 1.5% to reduce lines and wrinkles by more than 35% within 28 days.

Retinol 78
article thumbnail

AI Scribes: Reducing Documentation Time and Uncovering New Ethical Challenges in Health Care

Dermatology Times

Since the first electronic medical record emerged in 1972, clinicians have found themselves increasingly trapped behind screens.

article thumbnail

Personalizing Protocols For Every Aspect of Your Client

Lipgloss and Aftershave

L+A Now Summer School! Personalizing Protocols For Every Aspect of Your Client Learn how to customize treatments, from holistic modalities to chemical peels and microneedling, and stay ahead in the evolving esthetics landscape! Aliesh Pierce, product formulation expert, Millicent Russon, microneedling expert, and Chandra Bredel join us to talk about providing exceptional service to all clients equally, regardless of their ethnicity, gender identity, or religious beliefs.

article thumbnail

Is OX40 Inhibition the Next Game Changer for Atopic Dermatitis?

Dermatology Times

Learn more about the OX40-OX40L pathway and 2 drugs heading toward phase 3 trials.

More Trending

article thumbnail

Comparing Energy-Based Devices for Acne

Dermatology Times

Although EBDs provided improvements over controls, they did not match the sebum reduction levels achieved by isotretinoin or hormonal therapies.

Sebum 48
article thumbnail

The Role of Nutrition on Aging 2024

Aesthetics Advisor

1. Chronological Age vs Biological Age Chronological age is the age that is marked by your "birthday", i.e. how old you are according to your birth certificate. Biological age is the age your "body" is and can be measured by parameters such as lean body mass, insulin resistance, cholesterol levels and exercise capacity. We all age but unfortunately, for many people their bodies wear out prematurely decades too soon. 2.

article thumbnail

Increasing Levels of Physical Activity Led to Improvements in Wellbeing, Psychological Health in Patients With Psoriasis

Dermatology Times

atients showed significant improvements in skin severity, quality of life, blood pressure, and cardiovascular health, with enhanced psychological well-being.

45
article thumbnail

Panthenol Hair Benefits: Unsung Hero of Hair Health

Aesthetics Advisor

In the ever-evolving world of hair care, we’re constantly bombarded with new ingredients promising to deliver luscious, healthy locks. Yet, one crucial component often flies under the radar—panthenol. Despite its proven benefits, many are unaware of its significance in maintaining hair health and the consequences of not incorporating it into their routine.

article thumbnail

Highlights From Illinois Society for Dermatology Physician Assistants Conference

Dermatology Times

Renata Block, MMS, PA-C, interviews fellow colleagues to discuss conference highlights, Psoriasis Awareness Month, community advocacy, and more.

article thumbnail

DermBiont’s SM-020 Produces “Prompt, Visible, and Robust” Tumor Responses in BCC

The Dermatology Digest

DermBiont’s SM-020 is performing well in an ongoing open label, multi-center Phase 2a study for the treatment of basal cell carcinoma (BCC), the Company reports. SM-020 is a first-in-class, patient-applied, topical kinase inhibitor. All nine treated BCCs (1 superficial, 4 nodular, and 4 infiltrating) across seven enrolled subjects to date showed “prompt, visible, and robust” tumor responses during treatment with SM-020 1% twice daily for 28 days, resulting in partial or total reduction of clinic

Clinic 36
article thumbnail

Exploring the Emotional Impact and Treatment Perspectives Across Cultures

Dermatology Times

Chesahna Kindred, MD, discusses the emotional impact and treatment perspectives across cultures.

article thumbnail

Supplements for Erectile Dysfunction 2024

Aesthetics Advisor

Erectile dysfunction, also known as impotence, is defined by difficulty getting and keeping an erection. It's been reported that more than half of men between the ages of 40 and 70 experience some form of ED. ED is often a symptom of another health problem. 1. What Causes Erectile Dysfunction a.Vascular - The narrowing of the arteries (called atherosclerosis) is one of the most common causes of ED.

article thumbnail

Vitiligo Case Discussions: Navigating Emotional, Psychological, and Insurance Challenges

Dermatology Times

Chesahna Kindred, MD, discusses the psychological and insurance challenges associated with vitiligo.

36
article thumbnail

Supplements for Prostate Cancer 2024

Aesthetics Advisor

1. Benign Prostatic Hyperplasia (BPH) The aging male is concern with prostate disease such as benign prostatic hyperplasia (BPH) which gives rise to urinary problems such as. Urinary frequency Poor flow hesitancy Terminal dribbling Nocturia BPH increases with age. The prostate enlarges and squeezes the urethra and hence encroaches on urinary flow. 2.

article thumbnail

Advanced Vitiligo Care: Strategies for Facial Involvement and Difficult Repigmentation Areas

Dermatology Times

Chesahna Kindred, MD, discusses strategies for facial involvement and difficult repigmentation areas in association with advanced vitiligo care.

Facials 36
article thumbnail

List Prices of Enbrel, Stelara Slashed by Close to 70% Through Medicare Price Negotiations

The Dermatology Digest

The list prices of Stelara (ustekinumab) and Enbrel (etanercept) for people on Medicare will be reduced by nearly 70% in 2026, the White House announced. This action is a result of the first round of Centers for Medicare & Medicaid Services (CMS) price negotiations with drugmakers. It comprises the 10 costliest prescription drugs under Medicare.

article thumbnail

Topical Ruxolitinib in Vitiligo: Real-World Experiences and Cultural Considerations

Dermatology Times

Chesahna Kindred, MD, discusses real-world experiences and cultural considerations associated with topical ruxolitinib for the treatment of vitiligo.